According to survey data compiled by the Washington Post, the great majority of transgender individuals have not sought out medical procedures to aid in their transition.
“Most trans adults say transitioning made them more satisfied with their lives,” a Washington Post poll, found. Of the 515 transgender persons polled, the vast majority have just “socially transitioned.”
This article expands upon:
Social transitions, such as changing one’s outward appearance, name, or pronouns, are common among transgender people, but medical transitions are rather uncommon. About a sixth of transgender persons have undergone gender-affirming surgery or another sort of medical treatment to modify their appearance, and only about a third have used hormone therapy or puberty suppression.
People who identify as transgender may seek medical help in the form of puberty suppressants, cross-sex hormone therapy, or any number of surgical procedures.
Some examples of “gender-affirming” surgical treatments are double mastectomies, hysterectomies, and phalloplasties. Some people even go through with surgical procedures designed to give them a more feminine appearance.
States such as Tennessee have been condemned by advocates for establishing laws intended to safeguard minors from exposure to puberty-blocking drugs, cross-sex hormones, and sex-conversion surgery. However, the great majority of persons who identify as transgender do not actually have surgery to change their gender.
Many of these medical treatments are profitable for the businesses that provide them, but are out of reach financially for most patients. Recent studies reveal a rapidly growing demand for so-called “gender-affirming” surgery, particularly in the North American market.
In a series of investigations, Breitbart News has found evidence of a concerted effort to promote transgender identification, especially among young people, on the part of surgical sex change clinics and the manufacturers of puberty blockers.
Breitbart News found that the “Gender Odyssey” conference, which encourages young people to identify as transgender and attempt to modify their sex, was supported by many surgical facilities that conduct sex change surgery.
Abbvie Pharmaceuticals, the producers of the puberty-blocking medicine Lupron, financially support the GenderCool Project, which promotes transgenderism among young people through public appearances and other forms of advertising.